ConductScience.org, home

Paper35637337

An early warning system for emerging SARS-CoV-2 variants.

Subissi L and 60 others. Nat Med, 2022. Cited by 61 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. An early warning system for emerging SARS-CoV-2 variants. Papers, record 35637337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35637337

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An early warning system for emerging SARS-CoV-2 variants.
PubMed
Journal
Nat Med
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
2.9
iCite
Revised in PubMed
2025-05-30
PubMed

Authors61

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Subissi LLorenzohttps://orcid.org/0000-0001-5147-575X
2von Gottberg AAnnehttps://orcid.org/0000-0002-0243-7455
3Thukral LLipi
4Worp NNathalie
5Oude Munnink BBBas Bhttps://orcid.org/0000-0002-9394-1189
6Rathore SSurabhi
7Abu-Raddad LJLaith Jhttps://orcid.org/0000-0003-0790-0506
8Aguilera XXimenahttps://orcid.org/0000-0002-8153-6733
9Alm EErik
10Archer BNBrett Nhttps://orcid.org/0000-0002-4144-1094
11Attar Cohen HHoma
12Barakat AAmal
13Barclay WSWendy Shttps://orcid.org/0000-0002-3948-0895
14Bhiman JNJinal Nhttps://orcid.org/0000-0001-6354-4003
15Caly LLeon
16Chand MMeera
17Chen MMark
18Cullinane AAnn
19de Oliveira TTulio
20Drosten CChristianhttps://orcid.org/0000-0001-7923-0519

Source PubMed

See all 61 authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
SARS-CoV-2Major topic
Humans

Source PubMed

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
001World Health OrganizationInternationalPubMedPubMed
206298/Z/17/ZWellcome TrustUnited KingdomPubMedPubMed
MR/R015600/1Medical Research CouncilUnited KingdomPubMedPubMed
ZIA AI001324Intramural NIH HHSUnited StatesZIAAI001324PubMed and NIHNIH RePORTER
ZIAAI001289NIHNIH RePORTER

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134,735,219Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles.Science2021https://conductscience.org/library/papers/34735219PubMed
233,723,411Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.Nature2021https://conductscience.org/library/papers/33723411PubMed
334,461,056Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.Lancet Infect Dis2022https://conductscience.org/library/papers/34461056PubMed
434,678,071Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques.Sci Adv2021https://conductscience.org/library/papers/34678071PubMed
535,025,969Advances and gaps in SARS-CoV-2 infection models.PLoS Pathog2022https://conductscience.org/library/papers/35025969PubMed
634,504,335The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology.Nat Med2021https://conductscience.org/library/papers/34504335PubMed
735,042,229Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.Nature2022https://conductscience.org/library/papers/35042229PubMed
835,042,228Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant.Nat Med2022https://conductscience.org/library/papers/35042228PubMed
935,102,311T cell responses to SARS-CoV-2 spike cross-recognize Omicron.Nature2022https://conductscience.org/library/papers/35102311PubMed
1035,474,744Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern.Cell Rep Med2022https://conductscience.org/library/papers/35474744PubMed
1135,014,856Predicting the mutational drivers of future SARS-CoV-2 variants of concern.Sci Transl Med2022https://conductscience.org/library/papers/35014856PubMed
1231,604,969Evolutionary, genetic, structural characterization and its functional implications for the influenza A (H1N1) infection outbreak in India from 2009 to 2017.Sci Rep2019https://conductscience.org/library/papers/31604969PubMed
1334,347,959SARS-CoV-2 Variants in Patients with Immunosuppression.N Engl J Med2021https://conductscience.org/library/papers/34347959PubMed
1433,172,935Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans.Science2021https://conductscience.org/library/papers/33172935PubMed
1533,804,556SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations.Viruses2021https://conductscience.org/library/papers/33804556PubMed
1633,761,326N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.Cell2021https://conductscience.org/library/papers/33761326PubMed
1733,684,923Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.Nature2021https://conductscience.org/library/papers/33684923PubMed
1834,931,886Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity.Sci Transl Med2022https://conductscience.org/library/papers/34931886PubMed
1934,166,617Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.Cell Rep2021https://conductscience.org/library/papers/34166617PubMed
2034,818,667The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.Nature2022https://conductscience.org/library/papers/34818667PubMed

See all 49 references

Cited by48

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
42,598,025Nipah virus and the lessons of COVID-19: are we prepared for the next pandemic threat?Infect Med (Beijing)2026https://conductscience.org/library/papers/42598025PubMed
42,390,251Tracking the shifting landscape of SARS-CoV-2 variants in Lebanon among healthcare workers and hospitalized patients.Microbiol Spectr2026https://conductscience.org/library/papers/42390251PubMed
42,137,592A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations.Mol Ther Adv2026https://conductscience.org/library/papers/42137592PubMed
42,009,860Risk of stroke following SARS-CoV-2 infection in a nationwide self-controlled case series study in qatar.Sci Rep2026https://conductscience.org/library/papers/42009860PubMed
41,832,161Optimizing global genomic surveillance for early detection of emerging SARS-CoV-2 variants.Nat Commun2026https://conductscience.org/library/papers/41832161PubMed
41,258,470A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023.Commun Med (Lond)2025https://conductscience.org/library/papers/41258470PubMed
41,062,635Effectiveness and durability of a fourth dose of ancestral-strain mRNA vaccines against SARS-CoV-2 infection: a nationwide matched cohort study in Qatar.Sci Rep2025https://conductscience.org/library/papers/41062635PubMed
40,177,126VirusWarn: A mutation-based early warning system to prioritize concerning SARS-CoV-2 and influenza virus variants from sequencing data.Comput Struct Biotechnol J2025https://conductscience.org/library/papers/40177126PubMed
40,139,840Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severities.BMJ Open Respir Res2025https://conductscience.org/library/papers/40139840PubMed
40,093,761Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in Qatar.Open Forum Infect Dis2025https://conductscience.org/library/papers/40093761PubMed
39,910,292Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron.Nature2025https://conductscience.org/library/papers/39910292PubMed
39,770,311Genomic Diversity and Evolution of Identified SARS-CoV-2 Variants in Iraq.Pathogens2024https://conductscience.org/library/papers/39770311PubMed
39,446,192Forecasting dominance of SARS-CoV-2 lineages by anomaly detection using deep AutoEncoders.Brief Bioinform2024https://conductscience.org/library/papers/39446192PubMed
39,236,073Surveillance strategies for the detection of new pathogen variants across epidemiological contexts.PLoS Comput Biol2024https://conductscience.org/library/papers/39236073PubMed
39,162,483Report of SARS-CoV-2 JN.1 variant in Morocco.Microbiol Resour Announc2024https://conductscience.org/library/papers/39162483PubMed
38,720,002An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution.Nat Med2024https://conductscience.org/library/papers/38720002PubMed
38,640,902SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs.Cell Chem Biol2024https://conductscience.org/library/papers/38640902PubMed
38,632,281Data-driven recombination detection in viral genomes.Nat Commun2024https://conductscience.org/library/papers/38632281PubMed
38,529,118Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation.Front Med (Lausanne)2024https://conductscience.org/library/papers/38529118PubMed
38,515,050Characteristics of infections with ancestral, Beta and Delta variants of SARS-CoV-2 in the PHIRST-C community cohort study, South Africa, 2020-2021.BMC Infect Dis2024https://conductscience.org/library/papers/38515050PubMed

See all 48 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35637337

GET https://conductscience.org/api/papers/v1/35637337/authors?page=2